Latest Regulatory Milestones News

Odyssey Gold Limited has successfully raised approximately $9 million through a placement to fund accelerated development at its Tuckanarra Gold Project in Western Australia.

Toubani Resources has launched its largest-ever drilling program at the Kobada Gold Project in Mali, aiming to significantly grow its resource base with up to 100,000 metres of drilling in 2026. Recent high-grade drill results outside the current resource estimate bolster expectations for a substantial update.

Biotron Limited has completed the acquisition of Sedarex Limited alongside a $2.5 million capital raising, while its lead Hepatitis B drug candidate BIT-HBV001 shows promising preclinical results outperforming current treatments.

Arovella Therapeutics has secured a crucial regulatory nod from the U.S. FDA, allowing its lead CAR-iNKT cell therapy, ALA-101, to enter first-in-human clinical trials targeting blood cancers.

PainChek has secured FDA-regulated medical device status, enabling US Remote Therapeutic Monitoring reimbursement and opening a major US growth avenue. The company targets musculoskeletal pain management in non-verbal dementia patients, a largely underserved market.

Vitrafy Life Sciences has marked significant progress in Q2 FY2026 with a strategic partnership, commercial launch in North America, and advancing clinical trials, underpinning its growth in cryopreservation technology.

BPH Energy’s December quarter report reveals significant progress in its investee projects amid ongoing legal challenges and strategic capital management. The company balances judicial reviews, regulatory milestones, and funding plans across energy and medical technology sectors.

Chimeric Therapeutics reports encouraging clinical progress in its CAR-T and NK cell therapy trials, alongside FDA orphan drug designation and a strategic funding boost to propel development.

Meteoric Resources has cleared a major regulatory hurdle with the approval of its Preliminary Environmental License for the Caldeira Rare Earths Project, enabling the company to progress towards construction and first production targeted for 2028. The company also commissioned its pilot plant, producing its first batches of rare earth carbonate.

Megado Minerals is poised to advance its Iberian Copper Project with investigation permits expected early 2026, setting the stage for airborne geophysics and maiden drilling. Meanwhile, the company maintains strong positions in Canadian lithium and gold assets.

Emerald Resources NL has announced a significant update to its Dingo Range Gold Project in Western Australia, increasing its mineral resource to 1.41 million ounces of gold and securing full mining permits ahead of planned development in 2026.

EMVision Medical Devices reports strong clinical trial progress for its portable brain scanners, backed by solid cash reserves and milestone grant funding.